News
Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson, marking the latest twist in an unusual run leading the FDA office overseeing vaccines and gene therapy.
The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug ...
In line with the Trump administration’s goal to curb the U.S.’ reliance on overseas drug manufacturing, the FDA has deployed ...
The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...
The U.S. Food and Drug Administration said on Friday it has approved Boehringer Ingelheim's drug for patients with a type of ...
Boehringer Ingelheim GmbH won approval in the US for its drug to treat a challenging form of lung cancer, offering a growth ...
The shortage partly stems from Baxter International's North Carolina plant getting damaged in Hurricane Helene last year. At ...
The FDA Thursday announced a program that seeks to strengthen domestic drug manufacturing by increasing regulatory ...
Orange juice has been criticized for its sugar content, and possible regulations could lower the levels. Experts share their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback